COVID-19 Vaccine?

WHAT’S IN IT – AND WHY?

By Un-Biased Science

***

***

3 Responses

  1. Waldemar Haffkine:
    The vaccine pioneer the world forgot
    https://www.bbc.com/news/world-asia-india-55050012?utm_source=pocket-newtab
    Dr. David E. Marcinko MBA

    Like

  2. State Flu Vaccination Rates for Adults in 2019

    1. 13 states had vaccination rates from 32.5% to 41.2%: Alaska, Arizona, Florida, Georgia, Idaho, Illinois, Michigan, Mississippi, Louisiana, Nevada, Tennessee, Texas, Wyoming.
    2. 12 states had vaccination rates from 41.4% to 43.7%: Alabama, Arkansas, California, Hawaii, Indiana, Kentucky, Montana, New Mexico, Ohio, Oregon, South Carolina, Utah.
    3. 13 states had vaccination rates from 43.8% to 47.7%: Colorado, Delaware, Kansas, Maine, Minnesota, Missouri, New Hampshire, New York, North Dakota, Oklahoma, Vermont, West Virginia, Wisconsin.
    4. 11 states plus DC had rates from 47.9% to 50.5%: Connecticut, Washington DC, Iowa, Maryland, Massachusetts, Nebraska, North Carolina, Pennsylvania, Rhode Island, South Dakota, Virginia, Washington.

    Notes: From an article entitled, “How Prepared Are States to Vaccinate the Public Against COVID-19? Learning from Influenza and H1N1 Vaccination Programs.” New Jersey not included because of state reporting errors. Rates are for flu vaccinations of adults ages 18 and over.

    Source: The Commonwealth Fund, December 3, 2020

    Like

  3. UPDATE Oral Agents

    Currently, there are three antivirals that seem “promising” in combating COVID-19 in its early stages, according to Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases. The top medication as of right now is molnupiravir from Merck&Co. and Ridgeback Biotherapeutics. Following behind are Pfizer’s antiviral, PF-07321332, and Roche and Atea Pharmaceuticals’ AT-527.

    How do these antiviral medications work, exactly?

    Essentially, they hinder the virus’s ability to replicate in human cells. Currently, only one antiviral drug, known as remdesivir, has been approved to treat COVID-19. However, it’s not an oral drug and it’s also not intended for widespread use. It’s given to patients who’ve been hospitalized from COVID-19.

    Kisha

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: